Veterinary Renal Disease Market: Research In-Depth Analysis, Applications, Forecast To 2033

The new report published by The Business Research Company, titled ""Veterinary Renal Disease Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the veterinary renal disease market size has grown strongly in recent years. It will grow from $14.55 billion in 2023 to $15.33 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The veterinary renal disease market size is expected to see strong growth in the next few years. It will grow to $20.36 billion in 2028 at a compound annual growth rate (CAGR) of 7%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15957&type=smp

Increasing Pet Ownership Fuels Growth In The Veterinary Renal Disease Market
The increased pet ownership is expected to propel the growth of the veterinary renal disease market going forward. Veterinary renal disease refers to conditions affecting the kidneys in animals, leading to impaired kidney function and potentially resulting in symptoms such as increased thirst, frequent urination, loss of appetite, and weight loss. The increasing veterinary renal disease is driven by longer pet lifespans, exposure to environmental toxins, dietary factors, and genetic predispositions. Veterinary renal disease treatments for pets typically involve dietary management, medication, and fluid therapy to alleviate symptoms, slow disease progression, and improve quality of life. For instance, in October 2022, according to Cooper Pet Care, a Netherlands-based mobile pet care platform, there will be approximately 145 million pet animals in the European Union, which includes Norway and Switzerland. This marks a rise of 5 million compared to the count in 2021, which stood at around 140 million pets. This population includes about 66 million dogs and 79 million cats. Therefore, increasing pet ownership is driving the growth of the veterinary renal disease market.

Launche Of First Diagnostic Test For Early Detection Of Kidney Injury In Pets
Major companies operating in the veterinary renal disease market are focusing on developing technical advancements in treatment and diagnosis, such as novel diagnostic tests with the ability to detect kidney injury even when clinical signs may not be apparent. Diagnostic tests capable of detecting kidney injury with an aim to identify subtle changes in renal function or structure, facilitating early intervention to prevent progression to advanced stages of renal dysfunction. For instance, in June 2023, IDEXX Laboratories Inc., a US-based developer and manufacturer of veterinary products and services, launched the first veterinary diagnostic test for detecting kidney injury in cats and dogs. This test, known as the IDEXX Cystatin B Test, is designed to help veterinarians identify kidney injury before changes in kidney function become apparent, ultimately leading to better patient outcomes. The IDEXX Cystatin B Test will be integrated into test panels that assess renal health, providing valuable insights during an estimated two million patient visits annually.

The veterinary renal disease market covered in this report is segmented -

1) By Type: Diagnosis, Treatment
2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types
3) By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other Indications
4) By Route of Administration: Injectable, Oral
5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other Distribution Channels

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15957&type=discount

Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim , Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc. , IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Clinical Renal Associates, Veterinary Transplant Services Inc., Kibow Biotech Inc., Northwest Renal Clinic

Contents of the report:
1. Executive Summary
2. Veterinary Renal Disease Market Report Structure
3. Veterinary Renal Disease Market Trends And Strategies
4. Veterinary Renal Disease Market - Macro Economic Scenario
5. Veterinary Renal Disease Market Size And Growth
…..
27. Veterinary Renal Disease Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.